描述
Risk of bias assessment across included randomized controlled trials in the AGA treatment network meta-analysis, evaluated using the Cochrane Risk of Bias tool domains.
FIGURE 6
ChartSource Paper
Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A systematic review and continuous Bayesian network meta-analysis.Cite This Figure
 > Source: Peter R Feldman et al. "Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A syst." *Frontiers in medicine*, 2022. PMID: [36755885](https://pubmed.ncbi.nlm.nih.gov/36755885/)
<figure> <img src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900126/bin/fmed-09-998623-g006.jpg" alt="Risk of bias assessment across included randomized controlled trials in the AGA treatment network meta-analysis, evaluated using the Cochrane Risk of Bias tool domains." /> <figcaption>FIGURE 6. Risk of bias assessment across included randomized controlled trials in the AGA treatment network meta-analysis, evaluated using the Cochrane Risk of Bias tool domains.<br> Source: Peter R Feldman et al. "Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A syst." <em>Frontiers in medicine</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36755885/">36755885</a></figcaption> </figure>
相关证据
A
米诺地尔(Minoxidil) 用于 雄激素性脱发
A
等级 A · 299 项研究
非那雄胺(Finasteride) 用于 雄激素性脱发
A
等级 A · 206 项研究
Nutrafol 用于 雄激素性脱发
A
等级 A · 3 项研究
低能量激光疗法(LLLT) 用于 雄激素性脱发
A
等级 A · 60 项研究
Viviscal 用于 休止期脱发
A
等级 A · 8 项研究
Viviscal 用于 年龄相关性头发稀疏
A
等级 A · 8 项研究
Nutrafol 用于 女性型脱发
A
等级 A · 8 项研究
Nutrafol 用于 压力性脱发
A
等级 A · 8 项研究
度他雄胺(Dutasteride) 用于 雄激素性脱发
等级 A · 99 项研究